Intravenous Methylprednisolone in Guillain–Barré Syndrome: The Way Forward
Open Access
- 1 March 2025
- journal article
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 28 (2) , 180-181
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in AdultsCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2024
- The three pillars in treating antibody-mediated encephalitisWiener klinische Wochenschrift, 2023
- Corticosteroids for Guillain-Barré syndromeCochrane Database of Systematic Reviews, 2016
- CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trialsJournal of Clinical Epidemiology, 2010
- Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trialThe Lancet, 2004
- Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group.1993
- Randomisation and baseline comparisons in clinical trialsThe Lancet, 1990